Could the eIF2α-independent translation be the achilles heel of cancer?

Frontiers in Oncology

Volumn 5, Issue NOV, 2015, Pages

  Holcik, Martin ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Apoptosis; eIF2 ; IRES; Oncogene; Selective translation; Stress

Indexed keywords

APOPTOSIS; NEOPLASM; PHOSPHORYLATION; PROTEIN EXPRESSION; RNA TRANSLATION; SHORT SURVEY; STIMULATION;

EID: 84949741470     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00264     Document Type: Short Survey

References (72)

1. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. Global quantification of mammalian gene expression control. Nature (2011) 473:337-42. doi: 10.1038/nature10098.
2. Tebaldi T, Re A, Viero G, Pegoretti I, Passerini A, Blanzieri E, et al. Widespread uncoupling between transcriptome and translatome variations after a stimulus in mammalian cells. BMC Genomics (2012) 13:220. doi:10.1186/1471-2164-13-220.
3. Koromilas AE. Roles of the translation initiation factor eIF2alpha serine 51 phosphorylation in cancer formation and treatment. Biochim Biophys Acta (2015) 1849:871-80. doi:10.1016/j.bbagrm.2014.12.007.
4. Ron D, Harding HP. eIF2a Phosphorylation in Cellular Stress Responses and Disease. New York, NY: Cold Spring Harbor Laboratory Press (2007).
5. Ranu RS, London IM. Regulation of protein synthesis in rabbit reticulocyte lysates: additional initiation factor required for formation of ternary complex (eIF-2.GTP. Met-tRNAf) and demonstration of inhibitory effect of heme-regulated protein kinase. Proc Natl Acad Sci U S A (1979) 76:1079-83. doi:10.1073/pnas.76.3.1079.
6. Matts RL, Schatz JR, Hurst R, Kagen R. Toxic heavy metal ions activate the heme-regulated eukaryotic initiation factor-2 alpha kinase by inhibiting the capacity of hemin-supplemented reticulocyte lysates to reduce disulfide bonds. J Biol Chem (1991) 266:12695-702.
7. Lu L, Han AP, Chen JJ. Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses. Mol Cell Biol (2001) 21:7971-80. doi:10.1128/MCB.21.23.7971-7980.2001.
8. Taylor DR, Lee SB, Romano PR, Marshak DR, Hinnebusch AG, Esteban M, et al. Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol Cell Biol (1996) 16:6295-302. doi:10.1128/MCB.16.11.6295.
9. Samuel CE. Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc Natl Acad Sci U S A (1979) 76:600-4. doi:10.1073/pnas.76.2.600.
10. Roussou I, Thireos G, Hauge BM. Transcriptional-translational regulatory circuit in Saccharomyces cerevisiae which involves the GCN4 transcriptional activator and the GCN2 protein kinase. Mol Cell Biol (1988) 8:2132-9. doi:10.1128/MCB.8.5.2132.
11. Jiang HY, Wek RC. GCN2 phosphorylation of eIF2alpha activates NF-kappaB in response to UV irradiation. Biochem J (2005) 385:371-80. doi:10.1042/BJ20041164.
12. Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature (1999) 397:271-4. doi:10.1038/16729.
13. Wu S, Hu Y, Wang J-L, Chatterjee M, Shi Y, Kaufman RJ. Ultraviolet light inhibits translation through activation of the unfolded protein response kinase PERK in the lumen of the endoplasmic reticulum. J Biol Chem (2002) 277:18077-83. doi:10.1074/jbc. M110164200.
14. Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol (2005) 6:318-27. doi:10.1038/nrm1618.
15. Gaccioli F, Huang CC, Wang C, Bevilacqua E, Franchi-Gazzola R, Gazzola GC, et al. Amino acid starvation induces the SNAT2 neutral amino acid transporter by a mechanism that involves eukaryotic initiation factor 2alpha phosphorylation and cap-independent translation. J Biol Chem (2006) 281:17929-40. doi:10.1074/jbc. M600341200.
16. Aird KM, Ding X, Baras A, Wei J, Morse MA, Clay T, et al. Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression. Mol Cancer Ther (2008) 7:38-47. doi:10.1158/1535-7163.mct-07-0370.
17. Aird KM, Ghanayem RB, Peplinski S, Lyerly HK, Devi GR. X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor. Mol Cancer Ther (2010) 9:1432-42. doi:10.1158/1535-7163.mct-10-0160.
18. Muaddi H, Majumder M, Peidis P, Papadakis AI, Holcik M, Scheuner D, et al. Phosphorylation of eIF2alpha at serine 51 is an important determinant of cell survival and adaptation to glucose deficiency. Mol Biol Cell (2010) 21:3220-31. doi:10.1091/mbc. E10-01-0023.
19. Holcik M, Lefebvre C, Yeh C, Chow T, Korneluk RG. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat Cell Biol (1999) 1:190-2. doi:10.1038/11109.
20. Riley A, Jordan LE, Holcik M. Distinct 5' UTRs regulate XIAP expression under normal growth conditions and during cellular stress. Nucleic Acids Res (2010) 38:4665-74. doi:10.1093/nar/gkq241.
21. Thakor N, Holcik M. IRES-mediated translation of cellular messenger RNA operates in eIF2alpha-independent manner during stress. Nucleic Acids Res (2012) 40:541-52. doi:10.1093/nar/gkr701.
22. Warnakulasuriyarachchi D, Cerquozzi S, Cheung HH, Holcik M. Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element. J Biol Chem (2004) 279:17148-57. doi:10.1074/jbc. M308737200.
23. Silvera D, Arju R, Darvishian F, Levine PH, Zolfaghari L, Goldberg J, et al. Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol (2009) 11:903-8. doi:10.1038/ncb1900.
24. Silvera D, Schneider RJ. Inflammatory breast cancer cells are constitutively adapted to hypoxia. Cell Cycle (2009) 8:3091-6. doi:10.4161/cc.8.19.9637.
25. Bevilacqua E, Wang X, Majumder M, Gaccioli F, Yuan CL, Wang C, et al. eIF2alpha phosphorylation tips the balance to apoptosis during osmotic stress. J Biol Chem (2010) 285:17098-111. doi:10.1074/jbc. M110.109439.
26. Allam H, Ali N. Initiation factor eIF2-independent mode of c-Src mRNA translation occurs via an internal ribosome entry site. J Biol Chem (2010) 285:5713-25. doi:10.1074/jbc. M109.029462.
27. Shi Y, Yang Y, Hoang B, Bardeleben C, Holmes B, Gera J, et al. Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stress. Oncogene (2015) 11:156. doi:10.1038/onc.2015.156.
28. Pelletier J, Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature (1988) 334:320-5. doi:10.1038/334320a0.
29. Jackson RJ. The current status of vertebrate cellular mRNA IRESs. Cold Spring Harb Perspect Biol (2013) 5:a011569. doi:10.1101/cshperspect.a011569.
30. Johannes G, Carter MS, Eisen MB, Brown PO, Sarnow P. Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc Natl Acad Sci U S A (1999) 96:13118-23. doi:10.1073/pnas.96.23.13118.
31. Sachs AB, Sarnow P, Hentze MW. Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell (1997) 89:831-8. doi:10.1016/S0092-8674(00)80268-8.
32. Holcik M, Sonenberg N, Korneluk RG. Internal ribosome initiation of translation and the control of cell death. Trends Genet (2000) 16:469-73. doi:10.1016/S0168-9525(00)02106-5.
33. Lewis SM, Holcik M. IRES in distress: translational regulation of the inhibitor of apoptosis proteins XIAP and HIAP2 during cell stress. Cell Death Differ (2005) 12:547-53. doi:10.1038/sj.cdd.4401602.
34. Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nat Rev Cancer (2010) 10:254-66. doi:10.1038/nrc2824.
35. Elroy-Stein O, Merrick W. Translation initiation via cellular internal ribosome entry sites. In: Mathews MB, Sonenberg N, Hershey J, editors. Translational Control in Biology and Medicine. Cold Spring Harbor: Cold Spring Harbor Laboratory Press (2007). p. 155-72.
36. Yoon A, Peng G, Brandenburg Y, Zollo O, Xu W, Rego E, et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science (2006) 312:902-6. doi:10.1126/science.1123835.
37. Bellodi C, Kopmar N, Ruggero D. Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J (2010) 29:1865-76. doi:10.1038/emboj.2010.83.
38. Bellodi C, Krasnykh O, Haynes N, Theodoropoulou M, Peng G, Montanaro L, et al. Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res (2010) 70:6026-35. doi:10.1158/0008-5472.CAN-09-4730.
39. Braunstein S, Karpisheva K, Pola C, Goldberg J, Hochman T, Yee H, et al. A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell (2007) 28:501-12. doi:10.1016/j.molcel.2007.10.019.
40. Gu L, Zhu N, Zhang H, Durden DL, Feng Y, Zhou M. Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell (2009) 15:363-75. doi:10.1016/j.ccr.2009.03.002.
41. Mizrachy-Schwartz S, Kravchenko-Balasha N, Ben-Bassat H, Klein S, Levitzki A. Optimization of energy-consuming pathways towards rapid growth in HPV-transformed cells. PLoS One (2007) 2:e628. doi:10.1371/journal.pone.0000628.
42. Jan E, Kinzy TG, Sarnow P. Divergent tRNA-like element supports initiation, elongation, and termination of protein biosynthesis. Proc Natl Acad Sci U S A (2003) 100(26):15410-5. doi:10.1073/pnas.2535183100.
43. Pestova TV, de Breyne S, Pisarev AV, Abaeva IS, Hellen CU. eIF2-dependent and eIF2-independent modes of initiation on the CSFV IRES: a common role of domain II. EMBO J (2008) 27:1060-72. doi:10.1038/emboj.2008.49.
44. Terenin IM, Dmitriev SE, Andreev DE, Shatsky IN. Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2. Nat Struct Mol Biol (2008) 6:6. doi:10.1038/nsmb.1445.
45. Yamamoto H, Unbehaun A, Loerke J, Behrmann E, Collier M, Burger J, et al. Structure of the mammalian 80S initiation complex with initiation factor 5B on HCV-IRES RNA. Nat Struct Mol Biol (2014) 21:721-7. doi:10.1038/nsmb.2859.
46. Dmitriev SE, Terenin IM, Andreev DE, Ivanov PA, Dunaevsky JE, Merrick WC, et al. GTP-independent tRNA delivery to the ribosomal P-site by a novel eukaryotic translation factor. J Biol Chem (2010) 285:26779-87. doi:10.1074/jbc. M110.119693.
47. Skabkin MA, Skabkina OV, Dhote V, Komar AA, Hellen CU, Pestova TV. Activities of ligatin and MCT-1/DENR in eukaryotic translation initiation and ribosomal recycling. Genes Dev (2010) 24:1787-801. doi:10.1101/gad.1957510.
48. Schleich S, Strassburger K, Janiesch PC, Koledachkina T, Miller KK, Haneke K, et al. DENR-MCT-1 promotes translation re-initiation downstream of uORFs to control tissue growth. Nature (2014) 512:208-12. doi:10.1038/nature13401.
49. Skabkin MA, Skabkina OV, Hellen CU, Pestova TV. Reinitiation and other unconventional posttermination events during eukaryotic translation. Mol Cell (2013) 51:249-64. doi:10.1016/j.molcel.2013.05.026.
50. Rubtsova MP, Sizova DV, Dmitriev SE, Ivanov DS, Prassolov VS, Shatsky IN. Distinctive properties of the 5'-untranslated region of human hsp70 mRNA. J Biol Chem (2003) 278:22350-6. doi:10.1074/jbc. M303213200.
51. Shi Y, Sharma A, Wu H, Lichtenstein A, Gera J. Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK-and ERK-dependent pathway. J Biol Chem (2005) 280:10964-73. doi:10.1074/jbc. M407874200.
52. Bushell M, Wood W, Clemens MJ, Morley SJ. Changes in integrity and association of eukaryotic protein synthesis initiation factors during apoptosis. Eur J Biochem (2000) 267:1083-91. doi:10.1046/j.1432-1327.2000.01101.x.
53. Clemens MJ, Bushell M, Jeffrey IW, Pain VM, Morley SJ. Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ (2000) 7:603-15. doi:10.1038/sj.cdd.4400695.
54. Jeffrey IW, Bushell M, Tilleray VJ, Morley S, Clemens MJ. Inhibition of protein synthesis in apoptosis: differential requirements by the tumor necrosis factor alpha family and a DNA-damaging agent for caspases and the double-stranded RNA-dependent protein kinase. Cancer Res (2002) 62:2272-80.
55. Prosniak M, Dierov J, Okami K, Tilton B, Jameson B, Sawaya BE, et al. A novel candidate oncogene, MCT-1, is involved in cell cycle progression. Cancer Res (1998) 58:4233-7.
56. Nandi S, Reinert LS, Hachem A, Mazan-Mamczarz K, Hagner P, He H, et al. Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage. Oncogene (2007) 26:2283-9. doi:10.1038/sj.onc.1210447.
57. Mazan-Mamczarz K, Hagner PR, Corl S, Srikantan S, Wood WH, Becker KG, et al. Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene (2008) 27:6151-63. doi:10.1038/onc.2008.215.
58. Mazan-Mamczarz K, Hagner P, Dai B, Corl S, Liu Z, Gartenhaus RB. Targeted suppression of MCT-1 attenuates the malignant phenotype through a translational mechanism. Leuk Res (2009) 33:474-82. doi:10.1016/j.leukres.2008.08.012.
59. Shih HJ, Chen HH, Chen YA, Wu MH, Liou GG, Chang WW, et al. Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity. Oncotarget (2012) 3:1401-15. doi:10.18632/oncotarget.688.
60. Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, et al. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol (2002) 169:1102-9. doi:10.4049/jimmunol.169.2.1102.
61. Perez-Arellano I, Gallego J, Cervera J. The PUA domain-a structural and functional overview. FEBS J (2007) 274:4972-84. doi:10.1111/j.1742-4658.2007.06031.x.
62. Jack K, Bellodi C, Landry DM, Niederer RO, Meskauskas A, Musalgaonkar S, et al. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol Cell (2011) 44:660-6. doi:10.1016/j.molcel.2011.09.017.
63. Lee S, Truesdell SS, Bukhari SI, Lee JH, LeTonqueze O, Vasudevan S. Upregulation of eIF5B controls cell-cycle arrest and specific developmental stages. Proc Natl Acad Sci U S A (2014) 111:E4315-22. doi:10.1073/pnas.1320477111.
64. Pelletier J, GraffJ, Ruggero D, Sonenberg N. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development. Cancer Res (2015) 75:250-63. doi:10.1158/0008-5472.CAN-14-2789.
65. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res (2000) 6:1796-803.
66. Pardo OE, Lesay A, Arcaro A, Lopes R, Ng BL, Warne PH, et al. Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and Apoptosis in small cell lung cancer cells. Mol Cell Biol (2003) 23:7600-10. doi:10.1128/MCB.23.21.7600-7610.2003.
67. Schimmer AD, Welsh K, Pinilla C, Wang Z, Krajewska M, Bonneau MJ, et al. Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell (2004) 5:25-35. doi:10.1016/S1535-6108(03)00332-5.
68. Carter BZ, Gronda M, Wang Z, Welsh K, Pinilla C, AndreeffM, et al. Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells. Blood (2005) 105:4043-50. doi:10.1182/blood-2004-08-3168.
69. LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, Korneluk RG. IAP-targeted therapies for cancer. Oncogene (2008) 27:6252-75. doi:10.1038/onc.2008.302.
70. Flygare JA, Fairbrother WJ. Small-molecule pan-IAP antagonists: a patent review. Expert Opin Ther Pat (2010) 20:251-67. doi:10.1517/13543770903567077.
71. Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature (2006) 444:110-4. doi:10.1038/nature05257.
72. Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood (2010) 116:1079-82. doi:10.1182/blood-2010-01-256099.